| Product Code: ETC9692207 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Pharmaceutical Products and CMO Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Pharmaceutical Products and CMO Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Pharmaceutical Products and CMO Market - Industry Life Cycle |
3.4 Thailand Pharmaceutical Products and CMO Market - Porter's Five Forces |
3.5 Thailand Pharmaceutical Products and CMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Thailand Pharmaceutical Products and CMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Thailand |
4.2.2 Growing healthcare expenditure and investment in healthcare infrastructure |
4.2.3 Rising demand for generic drugs and biosimilars |
4.2.4 Favorable government regulations and initiatives to promote local pharmaceutical manufacturing |
4.3 Market Restraints |
4.3.1 Intense competition from established multinational pharmaceutical companies |
4.3.2 Regulatory challenges and compliance requirements |
4.3.3 Limited access to advanced technologies and skilled workforce in contract manufacturing |
5 Thailand Pharmaceutical Products and CMO Market Trends |
6 Thailand Pharmaceutical Products and CMO Market, By Types |
6.1 Thailand Pharmaceutical Products and CMO Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Pharmaceutical Products and CMO Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Thailand Pharmaceutical Products and CMO Market Revenues & Volume, By API and Ingredients, 2021- 2031F |
6.1.4 Thailand Pharmaceutical Products and CMO Market Revenues & Volume, By Finished Dosage Form, 2021- 2031F |
6.1.5 Thailand Pharmaceutical Products and CMO Market Revenues & Volume, By Pharmaceutical Packaging, 2021- 2031F |
7 Thailand Pharmaceutical Products and CMO Market Import-Export Trade Statistics |
7.1 Thailand Pharmaceutical Products and CMO Market Export to Major Countries |
7.2 Thailand Pharmaceutical Products and CMO Market Imports from Major Countries |
8 Thailand Pharmaceutical Products and CMO Market Key Performance Indicators |
8.1 Research and development (RD) investment in new drug development and manufacturing processes |
8.2 Number of partnerships and collaborations with local pharmaceutical companies and contract manufacturing organizations |
8.3 Adoption rate of digital technologies in pharmaceutical manufacturing processes |
8.4 Percentage of revenue derived from export markets |
8.5 Employee training and development initiatives to enhance manufacturing capabilities |
9 Thailand Pharmaceutical Products and CMO Market - Opportunity Assessment |
9.1 Thailand Pharmaceutical Products and CMO Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 Thailand Pharmaceutical Products and CMO Market - Competitive Landscape |
10.1 Thailand Pharmaceutical Products and CMO Market Revenue Share, By Companies, 2024 |
10.2 Thailand Pharmaceutical Products and CMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here